BIOCON.BOBIOCON.BOBSE
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+14.6%
5Y CAGR+14.2%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+14.6%/yr
vs +22.8%/yr prior
5Y CAGR
+14.2%/yr
Consistent
Acceleration
-8.2pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.9x
Solid growth
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $45.24B | +10.6% |
| 2024 | $40.90B | +12.6% |
| 2023 | $36.31B | +20.8% |
| 2022 | $30.07B | +30.6% |
| 2021 | $23.02B | -1.3% |
| 2020 | $23.31B | +44.0% |
| 2019 | $16.18B | +22.5% |
| 2018 | $13.22B | +14.0% |
| 2017 | $11.59B | +13.7% |
| 2016 | $10.19B | - |